Melanoma
Clinical Trials Menu
-
Breast - Oncology Research Studies
-
GI - Oncology Research Studies
-
GU/Prostate - Oncology Research Studies
-
Leukemia - Oncology Research Studies
-
Lung - Oncology Research Studies
-
Lymphoma - Oncology Research Studies
-
Melanoma - Oncology Research Studies
-
Multiple Myeloma - Oncology Research Studies
-
Other Oncology Research Studies
Melanoma Oncology Research Studies
RANDOMIZED PHASE II/III STUDY OF NIVOLUMAB PLUS IPILIMUMAB PLUS SARGRAMOSTIM VERSUS NIVOLUMAB PLUS IPILIMUMAB IN PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA
EA6141opens in a new tab
Contact Us
Give us a call to learn more about our oncology research studies.